Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study

The safety and efficacy of tocilizumab for the treatment of severe respiratory symptoms due to COVID-19 remain uncertain, in particular among solid organ transplant (SOT) recipients. Thus, we evaluated the clinical characteristics and outcomes of 29 hospitalized SOT recipients who received tocilizum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am J Transplant
Hauptverfasser: Pereira, Marcus R., Aversa, Meghan M., Farr, Maryjane A., Miko, Benjamin A., Aaron, Justin G., Mohan, Sumit, Cohen, David J., Husain, Syed A., Ratner, Lloyd E., Arcasoy, Selim, Uriel, Nir, Zheng, Elizabeth X., Fox, Alyson N., Tsapepas, Demetra S., Emond, Jean C., Verna, Elizabeth C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2020
Schlagworte:
Brief Communication
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537322/
https://ncbi.nlm.nih.gov/pubmed/32946668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.16314
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge